|
FDA Sets Dec. 3 Deadline for Self-Identification Under GDUFA
Generic-drug makers must submit self-identification information to the FDA by Dec. 3 to comply with the recently passed Generic Drug User Fee Amendments of 2012.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives